Pena Luis C.
Reporting owner on Forms 3, 4 and 5, CIK 1620548.
Pena Luis C. reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-11-17.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| Evommune, Inc. CIK 2044725 | director, officer (President & CEO) | 2 | 2026-11-17 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| EVMN · Evommune, Inc.Stock Option (Right to buy), derivative | 2026-11-13 | D returned to the issuer | -796,841 | 0 | Form 4 | |
| EVMN · Evommune, Inc.Stock Option (Right to buy), derivative | 2026-11-13 | A granted | +796,841 | 796,841 | Form 4 | |
| EVMN · Evommune, Inc.Stock Option (Right to buy), derivative | 2026-11-13 | D returned to the issuer | -291,420 | 0 | Form 4 | |
| EVMN · Evommune, Inc.Stock Option (Right to buy), derivative | 2026-11-13 | A granted | +291,420 | 291,420 | Form 4 | |
| EVMN · Evommune, Inc.Common Stock | 2026-09-30 | A granted | +1,115 | $7.02 | 631,573 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001620548-26-000011 | Evommune, Inc. | 2026-11-17 | ||
| Form 4 0001620548-26-000009 | Evommune, Inc. | 2026-10-15 |